BullFrog AI Holdings (BFRG) Other Accumulated Expenses (2022 - 2026)
BullFrog AI Holdings' (BFRG) quarterly Other Accumulated Expenses came in at $90138.0 in Q2 2026, up 350.69% quarter-over-quarter from $20000.0 in Q4 2024.
Analysis
BullFrog AI Holdings (BFRG) Other Accumulated Expenses (2022 - 2026) Analysis & Trends
BullFrog AI Holdings (BFRG) has reported Other Accumulated Expenses for 4 consecutive years, with $90138.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Accumulated Expenses changed N/A year-over-year to $90138.0; the trailing twelve-month figure through Jun 2026 stood at $90138.0 (changed N/A YoY), and the FY2024 full-year result was $20000.0, up 593.96% from the prior year.
- Other Accumulated Expenses rose to $90138.0 in Q2 2026 per BFRG's latest filing, from $20000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $133238.0 in Q4 2022 and bottomed at $2882.0 in Q4 2023.
- Historically, Other Accumulated Expenses has averaged $73258.3 across 4 years, with a median of $93392.0 in 2023.
- The sharpest annual moves came in 2023 and 2024: Other Accumulated Expenses tumbled 97.84% in 2023, then soared 593.96% in 2024.
- Over 4 years, Other Accumulated Expenses stood at $133238.0 in 2022, then sank by 97.84% to $2882.0 in 2023, then jumped by 593.96% to $20000.0 in 2024, then jumped by 350.69% to $90138.0 in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $90138.0, $20000.0, and $2882.0 for Q2 2026, Q4 2024, and Q4 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn |
| 10 | BullFrog AI Holdings | 9.27 Mn | 2.35 Mn | 106,899.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90,138.00 |
| Dec 31, 2024 | 20,000.00 |
| Dec 31, 2023 | 2,882.00 |
| Jun 30, 2023 | 96,646.00 |
| Mar 31, 2023 | 96,646.00 |
| Dec 31, 2022 | 133,238.00 |